Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine with dexmedetomidine to prevent postoperative delirium in pediatric surgery
ChiCTR2100048713Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of postoperative delirium within 5 days. Started Jul 2021; status: recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2100048713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048713.